Tumor Regression Patterns Based on Follow-up Duration in Patients With Head and Neck Squamous Cell Carcinoma Treated With Radiotherapy or Chemoradiotherapy
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives. We describe patterns of tumor regression based on follow-up duration after radiotherapy (RT) or chemo-RT in patients with head and neck squamous cell carcinoma. Methods. Thirty-one patients with head and neck squamous cell carcinoma were included in this study and received definitive RT or chemo-RT. The pattern of primary tumor regression after treatment was evaluated every 1 to 2 months. Predictive factors for the length of time to full regression were also analyzed. Results. Among all patients, 27 patients showed regression of the primary tumor, 24 patients showed >50% regression, and 15 patients showed total regression. The primary tumor gradually regressed during the course of follow-up. The median time to full regression was 5.2 months (range, 1.3 to 17.9 months). In the 24 patients who showed >50% regression, the rate of >50% regression increased over time as follows: 25.0% at 1 month, 62.5% at 2 months, 75.0% at 3 months, 91.7% at 4 months, and 95.8% at 5 months. Higher total RT dose and shorter RT duration were associated with longer time to full regression. Conclusion. A substantial number of patients showed continuous regression of the primary tumor for more than 2 months after treatment. The timing for evaluation of tumor regression must be greater than 2 months from the completion of RT or chemo-RT in patients with head and neck squamous cell carcinoma.
Abstract
Objectives. We describe patterns of tumor regression based on follow-up duration after radiotherapy (RT) or chemo-RT in patients with head and neck squamous cell carcinoma. Methods. Thirty-one patients with head and neck squamous cell carcinoma were included in this study and received definitive RT or chemo-RT. The pattern of primary tumor regression after treatment was evaluated every 1 to 2 months. Predictive factors for the length of time to full regression were also analyzed. Results. Among all patients, 27 patients showed regression of the primary tumor, 24 patients showed >50% regression, and 15 patients showed total regression. The primary tumor gradually regressed during the course of follow-up. The median time to full regression was 5.2 months (range, 1.3 to 17.9 months). In the 24 patients who showed >50% regression, the rate of >50% regression increased over time as follows: 25.0% at 1 month, 62.5% at 2 months, 75.0% at 3 months, 91.7% at 4 months, and 95.8% at 5 months. Higher total RT dose and shorter RT duration were associated with longer time to full regression. Conclusion. A substantial number of patients showed continuous regression of the primary tumor for more than 2 months after treatment. The timing for evaluation of tumor regression must be greater than 2 months from the completion of RT or chemo-RT in patients with head and neck squamous cell carcinoma.
참고문헌 (15)
- Dias FL, "Assessment of treatment response after chemoradiation of head and neck cancer", Curr Oncol Rep, 15(2), pp.119~127 (2013)
- 정송미, "Re-irradiation of unresectable recurrent head and neck cancer: using Helical Tomotherapy as image-guided intensity-modulated radiotherapy", Radiation oncology journal, 31(4), pp.206~215 (2013), 대한방사선종양학회
- Joshi A, "Current trends in the follow-up of head and neck cancer patients in the UK", Clin Oncol (R Coll Radiol), 22(2), pp.114~118 (2010)
- de Visscher AV, "Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity. Does it make sense?", Arch Otolaryngol Head Neck Surg, 120(9), pp.934~939 (1994)
- Cooney TR, "Is routine follow-up useful after combined-modality therapy for advanced head and neck cancer?", Arch Otolaryngol Head Neck Surg, 125(4), pp.379~382 (1999)
- Kothari P, "The follow-up of patients with head and neck cancer: an analysis of 1,039 patients", Eur Arch Otorhinolaryngol, 268(8), pp.1191~1200 (2011)
- Saito N, "Posttreatment CT and MR imaging in head and neck cancer: what the radiologist needs to know", Radiographics, 32(5), pp.1261~1282 (2012)
- Lell M, "Head and neck tumors: imaging recurrent tumor and post-therapeutic changes with CT and MRI", Eur J Radiol, 33(3), pp.239~247 (2000)
- Offiah C, "Post-treatment imaging appearances in head and neck cancer patients", Clin Radiol, 66(1), pp.13~24 (2011)
- Mukherji SK, "Evaluation of head and neck squamous cell carcinoma after treatment", AJNR Am J Neuroradiol, 24(9), pp.1743~1746 (2003)
- Ojiri H, "CT findings at the primary site of oropharyngeal squamous cell carcinoma within 6-8 weeks after definitive radiotherapy as predictors of primary site control", Int J Radiat Oncol Biol Phys, 52(3), pp.748~754 (2002)
- Hermans R, "Mendenhall WM. Laryngeal or hypopharyngeal squamous cell carcinoma: can follow-up CT after definitive radiation therapy be used to detect local failure earlier than clinical examination alone?", Radiology, 214(3), pp.683~687 (2000)
- Passero VA, "Response assessment by combined PET-CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy", Ann Oncol, 21(11), pp.2278~2283 (2010)
- Sjovall J, "Radiotherapy response in head and neck cancer - evaluation of the primary tumour site", Acta Otolaryngol, 134(6), pp.646~651 (2014)
- Yom SS, "Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx", Am J Clin Oncol, 28(4), pp.385~392 (2005)